158 related articles for article (PubMed ID: 25904691)
1. A novel AARS mutation in a family with dominant myeloneuropathy.
Motley WW; Griffin LB; Mademan I; Baets J; De Vriendt E; De Jonghe P; Antonellis A; Jordanova A; Scherer SS
Neurology; 2015 May; 84(20):2040-7. PubMed ID: 25904691
[TBL] [Abstract][Full Text] [Related]
2. A recurrent loss-of-function alanyl-tRNA synthetase (AARS) mutation in patients with Charcot-Marie-Tooth disease type 2N (CMT2N).
McLaughlin HM; Sakaguchi R; Giblin W; ; Wilson TE; Biesecker L; Lupski JR; Talbot K; Vance JM; Züchner S; Lee YC; Kennerson M; Hou YM; Nicholson G; Antonellis A
Hum Mutat; 2012 Jan; 33(1):244-53. PubMed ID: 22009580
[TBL] [Abstract][Full Text] [Related]
3. Alanyl-tRNA synthetase mutation in a family with dominant distal hereditary motor neuropathy.
Zhao Z; Hashiguchi A; Hu J; Sakiyama Y; Okamoto Y; Tokunaga S; Zhu L; Shen H; Takashima H
Neurology; 2012 May; 78(21):1644-9. PubMed ID: 22573628
[TBL] [Abstract][Full Text] [Related]
4. Hypermorphic and hypomorphic AARS alleles in patients with CMT2N expand clinical and molecular heterogeneities.
Weterman MAJ; Kuo M; Kenter SB; Gordillo S; Karjosukarso DW; Takase R; Bronk M; Oprescu S; van Ruissen F; Witteveen RJW; Bienfait HME; Breuning M; Verhamme C; Hou YM; de Visser M; Antonellis A; Baas F
Hum Mol Genet; 2018 Dec; 27(23):4036-4050. PubMed ID: 30124830
[TBL] [Abstract][Full Text] [Related]
5. A major determinant for binding and aminoacylation of tRNA(Ala) in cytoplasmic Alanyl-tRNA synthetase is mutated in dominant axonal Charcot-Marie-Tooth disease.
Latour P; Thauvin-Robinet C; Baudelet-Méry C; Soichot P; Cusin V; Faivre L; Locatelli MC; Mayençon M; Sarcey A; Broussolle E; Camu W; David A; Rousson R
Am J Hum Genet; 2010 Jan; 86(1):77-82. PubMed ID: 20045102
[TBL] [Abstract][Full Text] [Related]
6. Alanyl-tRNA synthetase 1 (AARS1) gene mutation in a family with intermediate Charcot-Marie-Tooth neuropathy.
Lee AJ; Nam DE; Choi YJ; Nam SH; Choi BO; Chung KW
Genes Genomics; 2020 Jun; 42(6):663-672. PubMed ID: 32314272
[TBL] [Abstract][Full Text] [Related]
7. Genetic epidemiology of Charcot-Marie-Tooth disease.
Braathen GJ
Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
[TBL] [Abstract][Full Text] [Related]
8. Genotype/phenotype correlations in AARS-related neuropathy in a cohort of patients from the United Kingdom and Ireland.
Bansagi B; Antoniadi T; Burton-Jones S; Murphy SM; McHugh J; Alexander M; Wells R; Davies J; Hilton-Jones D; Lochmüller H; Chinnery P; Horvath R
J Neurol; 2015 Aug; 262(8):1899-908. PubMed ID: 26032230
[TBL] [Abstract][Full Text] [Related]
9. Clinical and pathological phenotype of the original family with Charcot-Marie-Tooth type 1B: a 20-year study.
Bird TD; Kraft GH; Lipe HP; Kenney KL; Sumi SM
Ann Neurol; 1997 Apr; 41(4):463-9. PubMed ID: 9124803
[TBL] [Abstract][Full Text] [Related]
10. Loss-of-function alanyl-tRNA synthetase mutations cause an autosomal-recessive early-onset epileptic encephalopathy with persistent myelination defect.
Simons C; Griffin LB; Helman G; Golas G; Pizzino A; Bloom M; Murphy JL; Crawford J; Evans SH; Topper S; Whitehead MT; Schreiber JM; Chapman KA; Tifft C; Lu KB; Gamper H; Shigematsu M; Taft RJ; Antonellis A; Hou YM; Vanderver A
Am J Hum Genet; 2015 Apr; 96(4):675-81. PubMed ID: 25817015
[TBL] [Abstract][Full Text] [Related]
11. Distal hereditary neuropathy associated with a novel mutation in alanyl-aminoacyl-tRNA synthetase.
Yuan Y; Hong D; Gao X; Zhang J
Clin Neuropathol; 2022; 41(6):271-276. PubMed ID: 36278300
[TBL] [Abstract][Full Text] [Related]
12. Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy.
Jordanova A; Irobi J; Thomas FP; Van Dijck P; Meerschaert K; Dewil M; Dierick I; Jacobs A; De Vriendt E; Guergueltcheva V; Rao CV; Tournev I; Gondim FA; D'Hooghe M; Van Gerwen V; Callaerts P; Van Den Bosch L; Timmermans JP; Robberecht W; Gettemans J; Thevelein JM; De Jonghe P; Kremensky I; Timmerman V
Nat Genet; 2006 Feb; 38(2):197-202. PubMed ID: 16429158
[TBL] [Abstract][Full Text] [Related]
13. Clinical and electrophysiological studies of a family with probable X-linked dominant Charcot-Marie-Tooth neuropathy and ptosis.
Wu T; Wang HL; Chu CC; Yu JM; Chen JY; Huang CC
Chang Gung Med J; 2004 Jul; 27(7):489-500. PubMed ID: 15508871
[TBL] [Abstract][Full Text] [Related]
14. An active dominant mutation of glycyl-tRNA synthetase causes neuropathy in a Charcot-Marie-Tooth 2D mouse model.
Seburn KL; Nangle LA; Cox GA; Schimmel P; Burgess RW
Neuron; 2006 Sep; 51(6):715-26. PubMed ID: 16982418
[TBL] [Abstract][Full Text] [Related]
15. Phenotypical features of the p.R120W mutation in the GDAP1 gene causing autosomal dominant Charcot-Marie-Tooth disease.
Sivera R; Espinós C; Vílchez JJ; Mas F; Martínez-Rubio D; Chumillas MJ; Mayordomo F; Muelas N; Bataller L; Palau F; Sevilla T
J Peripher Nerv Syst; 2010 Dec; 15(4):334-44. PubMed ID: 21199105
[TBL] [Abstract][Full Text] [Related]
16. Deficient activity of alanyl-tRNA synthetase underlies an autosomal recessive syndrome of progressive microcephaly, hypomyelination, and epileptic encephalopathy.
Nakayama T; Wu J; Galvin-Parton P; Weiss J; Andriola MR; Hill RS; Vaughan DJ; El-Quessny M; Barry BJ; Partlow JN; Barkovich AJ; Ling J; Mochida GH
Hum Mutat; 2017 Oct; 38(10):1348-1354. PubMed ID: 28493438
[TBL] [Abstract][Full Text] [Related]
17. Clinical and morphological variability of the E396K mutation in the neurofilament light chain gene in patients with Charcot-Marie- Tooth disease type 2E.
Elbracht M; Senderek J; Schara U; Nolte K; Klopstock T; Roos A; Reimann J; Zerres K; Weis J; Rudnik-Schöneborn S
Clin Neuropathol; 2014; 33(5):335-43. PubMed ID: 24887401
[TBL] [Abstract][Full Text] [Related]
18. CMT type 2N disease-associated AARS mutant inhibits neurite growth that can be reversed by valproic acid.
Tatsumi Y; Matsumoto N; Iibe N; Watanabe N; Torii T; Sango K; Homma K; Miyamoto Y; Sakagami H; Yamauchi J
Neurosci Res; 2019 Feb; 139():69-78. PubMed ID: 30261202
[TBL] [Abstract][Full Text] [Related]
19. [Two novel mutations of GJB1 gene associated with typical X-linked Charcot-Marie-Tooth disease].
Qiao XH; Li YX; Chang XZ; Luan XH; Chen B; Bu DF; Yuan Y
Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(47):3328-31. PubMed ID: 20193560
[TBL] [Abstract][Full Text] [Related]
20. A novel stop codon mutation in the PMP22 gene associated with a variable phenotype.
Abe KT; Lino AM; Hirata MT; Pavanello RC; Brotto MW; Marchiori PE; Zatz M
Neuromuscul Disord; 2004 May; 14(5):313-20. PubMed ID: 15099590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
